XOMA Royalty (XOMA) Profit After Tax (2011 - 2026)
XOMA Royalty (XOMA) reported Profit After Tax of $4.5 million for Q1 2026, up 88.64% on a YoY basis from $2.4 million in Q1 2025, and down 26.84% sequentially from $6.1 million in Q4 2025.
XOMA Royalty (XOMA) Profit After Tax (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Profit After Tax data on file, last reported at $4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 88.64% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $22.1 million (up 873.91% YoY), and the FY2025 full-year result was $31.7 million, up 329.45% from the prior year.
- Profit After Tax slipped to $4.5 million in Q1 2026, from $6.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $16.0 million in Q2 2024 to a low of -$20.1 million in Q4 2023.
- A 5-year average of -$3.1 million and a median of -$4.4 million in 2022 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 330.39% in 2023 and surged 396.02% in 2024, its largest moves.
- Tracing XOMA's Profit After Tax over 5 years: stood at -$6.0 million in 2022, then tumbled by 236.5% to -$20.1 million in 2023, then surged by 80.27% to -$4.0 million in 2024, then surged by 253.81% to $6.1 million in 2025, then fell by 26.84% to $4.5 million in 2026.
- Business Quant data shows XOMA's Profit After Tax at $4.5 million in Q1 2026, $6.1 million in Q4 2025, and $9.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Jun 30, 2025 | 9.19 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | -3.97 Mn |
| Sep 30, 2024 | -17.24 Mn |
| Jun 30, 2024 | 15.99 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Dec 31, 2023 | -20.11 Mn |
| Sep 30, 2023 | -5.51 Mn |
| Jun 30, 2023 | -5.40 Mn |
| Mar 31, 2023 | -9.81 Mn |
| Dec 31, 2022 | -5.98 Mn |
| Sep 30, 2022 | -4.18 Mn |
| Jun 30, 2022 | -4.67 Mn |
| Mar 31, 2022 | -2.28 Mn |
| Dec 31, 2021 | 29.84 Mn |
| Sep 30, 2021 | -4.44 Mn |
| Jun 30, 2021 | -2.24 Mn |
| Mar 31, 2021 | -7.37 Mn |